- Home
- NGS vs ALDX Comparison
NGS vs ALDX Comparison
Compare NGS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NGS
- ALDX
- Stock Information
- Founded
- NGS 1998
- ALDX 2004
- Country
- NGS United States
- ALDX United States
- Employees
- NGS N/A
- ALDX N/A
- Industry
- NGS Oilfield Services/Equipment
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- NGS Energy
- ALDX Health Care
- Exchange
- NGS Nasdaq
- ALDX Nasdaq
- Market Cap
- NGS 282.3M
- ALDX 304.9M
- IPO Year
- NGS 2002
- ALDX 2014
- Fundamental
- Price
- NGS $23.58
- ALDX $6.31
- Analyst Decision
- NGS Strong Buy
- ALDX Strong Buy
- Analyst Count
- NGS 2
- ALDX 2
- Target Price
- NGS $26.50
- ALDX $10.00
- AVG Volume (30 Days)
- NGS 66.1K
- ALDX 640.9K
- Earning Date
- NGS 03-17-2025
- ALDX 05-01-2025
- Dividend Yield
- NGS N/A
- ALDX N/A
- EPS Growth
- NGS 605.21
- ALDX N/A
- EPS
- NGS 1.28
- ALDX N/A
- Revenue
- NGS $152,305,000.00
- ALDX N/A
- Revenue This Year
- NGS $30.81
- ALDX N/A
- Revenue Next Year
- NGS $13.48
- ALDX N/A
- P/E Ratio
- NGS $18.45
- ALDX N/A
- Revenue Growth
- NGS 41.72
- ALDX N/A
- 52 Week Low
- NGS $16.70
- ALDX $2.75
- 52 Week High
- NGS $29.74
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- NGS 40.57
- ALDX 50.42
- Support Level
- NGS $20.22
- ALDX $6.79
- Resistance Level
- NGS $25.85
- ALDX $7.20
- Average True Range (ATR)
- NGS 1.08
- ALDX 0.60
- MACD
- NGS -0.06
- ALDX -0.01
- Stochastic Oscillator
- NGS 44.85
- ALDX 63.22
About NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.